Please assess the completion status of the following clinical trial:

Trial Title: Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women seeking care at the University of Rochester's Women's Health Practice Family Planning Clinic~* Undergoing second trimester surgical termination of pregnancy~* Proficient in reading, writing, and comprehending English~* Able to give informed consent~Exclusion Criteria:~* Not proficient in reading, writing, or comprehending English~* Not able to give informed consent~* Already taking antiemetics~* Doxycycline allergy~* Hyperemesis gravidarum~* History of gastroparesis or cyclical vomiting~* Unable to swallow pills

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): 160 Patients will randomly be assigned, using sealed numbered opaque envelopes to receive placebo tablet 30 minutes prior to taking 200mg PO doxycycline
- Ondansetron (Type: ACTIVE_COMPARATOR): 160 Patients will randomly be assigned, using sealed numbered opaque envelopes to receive 8mg ondansetron tablet 30 minutes prior to taking 200mg PO doxycycline

Based on this trial design, predict the completion outcome and termination type (if applicable).